The U.S. Food and Drug Administration (FDA) has approved Soolantra (ivermectin) Cream 1% for the treatment of rosacea, a condition that may include inflammatory lesions, bumps, pimples, and redness.  Rosacea is a common, but often misunderstood, skin disorder affecting 16 million Americans, particularly ages 30 and older. The cause of rosacea is unknown, but research suggests that there are multiple triggers.  Some triggers include the sun, alcohol, spicy food, and exercise.  Adam Hessel, M.D., a Board Certified Dermatologist at Buckeye Dermatology in Dublin Ohio, said, “Rosacea is a very common problem inRead More